Ativa’s rapid blood cell analyzer with in-built A.I. is designed to bring time-critical tests to the point of care.

Ativa provides your routine test results with deeper insights by using machine learning to detect the body’s earliest immune response to life-threatening conditions including sepsis and COVID-19.

The underlying technology was designed for detecting bio-warfare agents and co-developed with Honeywell and 3M.

LEARN MORE

Ativa’s rapid blood cell analyzer with in-built A.I. is designed to bring time-critical tests to the point of care.

Ativa provides your routine test results with deeper insights by using machine learning to detect the body’s earliest immune response to life-threatening conditions including sepsis and COVID-19.

The underlying technology was designed for detecting bio-warfare agents and co-developed with Honeywell and 3M.

LEARN MORE

Critical test results in minutes rather than hours

 

Ativa will enable clinicians with critical test results within 5-minutes at the point of care. Our machine learning models coupled with big data will deliver the deeper insights necessary to definitively diagnose, triage and treat patients.

 

Critical test results in minutes rather than hours

Ativa will enable clinicians with critical test results within 5-minutes at the point of care. Our machine learning models coupled with big data will deliver the deeper insights necessary to definitively diagnose, triage and treat patients.

More time healing, less time waiting

Delays in diagnosis can have substantial life-threatening and financial consequences. No more waiting hours for results or being sent home misdiagnosed. Just a drop of blood and immediate action.

More time healing, less time waiting

Delays in diagnosis can have substantial life-threatening and financial consequences. No more waiting hours for results or being sent home misdiagnosed. Just a drop of blood and immediate action.

Impacting global healthcare to improve lives everywhere

Ativa’s point of care system has the characteristics necessary to facilitate broad decentralization of blood testing across all sites of care. Coupled with machine learning, problem diseases can be addressed at a low cost and with widespread accessibility.

LEARN MORE

Impacting global healthcare to improve lives everywhere

Ativa’s point of care system has the characteristics necessary to facilitate broad decentralization of blood testing across all sites of care. Coupled with machine learning, problem diseases can be addressed at a low cost and with widespread accessibility.

LEARN MORE

We are experienced agents of disruption

 

Ativa’s team has successfully commercialized and implemented A.I.-based medical technologies before. We’ve launched companies on NASDAQ, and are a team made up of world class technologists, scientists, and partners creating valuable and innovative solutions.

LEARN MORE

We are experienced agents of disruption

 

Ativa’s team has successfully commercialized and implemented A.I.-based medical technologies before. We’ve launched companies on NASDAQ, and are a team made up of world class technologists, scientists, and partners creating valuable and innovative solutions.

LEARN MORE